CoChat

A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway

Open access
Yan, Han, Zhang, Bo, Li, Shao, Zhao, Qianchuan · 2010 · BMC Systems Biology

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Background: Drug combination therapy is commonly used in clinical practice. Many methods including Bliss independence method have been proposed for drug combination design based on simulations models or experiments. Although Bliss independence method can help to solve the drug combination design problem when there are only a small number of combinations, as the number of combinations increases, it may not be scalable. Exploration of system structure becomes important to reduce the complexity of the design problem. Results: In this paper, we deduced a mathematical model which can simplify the serial structure and parallel structure of biological pathway for synergy evaluation of drug combinations. We demonstrated in steady state the sign of the synergism assessment factor derivative of the original system can be predicted by the sign of its simplified system. In addition, we analyzed the influence of feedback structure on survival ratio of the serial structure. We provided a sufficient condition under which the combination effect could be maintained. Furthermore, we applied our method to find three synergistic drug combinations on tumor necrosis factor α-induced NFκB pathway and subsequently verified by the cell experiment. Conclusions: We identified several structural properties underlying the Bliss independence criterion, and developed a systematic simplification framework for drug combiation desgin by combining simulation and system reaction network topology analysis. We hope that this work can provide insights to tackle the challenging problem of assessment of combinational drug therapy effect in a large scale signaling pathway. And hopefully in the future our method could be expanded to more general criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1752-0509-4-50

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Serial structure. The left subfigure illustrate the general serial structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reaction B-P+C→C-P (or it also could be seen as target on component B-P) and component C.
Figure 1 Serial structure. The left subfigure illustrate the general serial structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reaction B-P+C→C-P (or it also could be seen as target on component B-P) and component C.CC BY · PubMed Central
Figure 2 Parallel structure. The left subfigure illustrate the general parallel structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reactions B1-P+C→C-P (or it also could be seen as target on component B1-P) and B2-P+C→C-P (or target on component B2-P).
Figure 2 Parallel structure. The left subfigure illustrate the general parallel structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reactions B1-P+C→C-P (or it also could be seen as target on component B1-P) and B2-P+C→C-P (or target on component B2-P).CC BY · PubMed Central
Figure 3 Illustration of feedback structures. R is the input of x. y is the output of the system. f is the intermediate process from x to y. g is the feedback function. a and b are affected parameters.
Figure 3 Illustration of feedback structures. R is the input of x. y is the output of the system. f is the intermediate process from x to y. g is the feedback function. a and b are affected parameters.CC BY · PubMed Central
Figure 4 S curves of Figure 1 and 2. In the simulation, we adopted the same doses of both inhibitors like [1]. The left subfigure is the simulation results of the serial structure in Figure 1. The right subfigure is the simulation results of the parallel structure in Figure 2. The S curves of original systems are in red. The blue curves are the S curves recovered from the results of simplified systems based on Lemma 1 and the two corollaries. In fact the S curve of the simplified serial system has opposite sign to that of the original serial system. Obviously the S curves recovered agreed with the original S curves. The signs of S curves are negative showing the synergistic effect of the serial and parallel structures. In left subfigure the absolute values of S are much small (10-3 order) to those of the S in right subfigure (10-1 order). Combination therapy of the parallel structure could be more effective. These results are conincident with the results in [1].
Figure 4 S curves of Figure 1 and 2. In the simulation, we adopted the same doses of both inhibitors like [1]. The left subfigure is the simulation results of the serial structure in Figure 1. The right subfigure is the simulation results of the parallel structure in Figure 2. The S curves of original systems are in red. The blue curves are the S curves recovered from the results of simplified systems based on Lemma 1 and the two corollaries. In fact the S curve of the simplified serial system has opposite sign to that of the original serial system. Obviously the S curves recovered agreed with the original S curves. The signs of S curves are negative showing the synergistic effect of the serial and parallel structures. In left subfigure the absolute values of S are much small (10-3 order) to those of the S in right subfigure (10-1 order). Combination therapy of the parallel structure could be more effective. These results are conincident with the results in [1].CC BY · PubMed Central
Figure 5 Negative feedback structure. This system with negative feedback loop (from [1]) is constructed based on the serial system in Figure 1 by adding a feedback loop (orange color) which is from the output C-P to the activation of B to the serial structure. The output of this system is still the concentration of activation C.
Figure 5 Negative feedback structure. This system with negative feedback loop (from [1]) is constructed based on the serial system in Figure 1 by adding a feedback loop (orange color) which is from the output C-P to the activation of B to the serial structure. The output of this system is still the concentration of activation C.CC BY · PubMed Central
Figure 6 Case study of TNF-α-induced NFκB pathway. A. The kinetic model of TNF-α-induced NFκB pathway. The dashed box area indicates the simplified system. B. Biological schematic of TNF-α-induced NFκB pathway. Not all arrows represent direct physical interactions. Drugs used in this study and their key targets are highlighted. C. HUVECs were pretreated with three combinations at the same concentration 100 nM for 2 hours before being stimulated with 10 ng/ml TNF-α for 6 hours. Cells were lysed and output signaling protein was probed by western blotting. The level of β-actin was used as an internal control for normalization. The gray values are recorded at the bottom. D. Ratio of ICAM-1 to β-actin was determined with densitometry. C, control, T, 10 ng/ml TNF-α, G, Geldanamycin, A, Aldehyde, P, PS-1145.
Figure 6 Case study of TNF-α-induced NFκB pathway. A. The kinetic model of TNF-α-induced NFκB pathway. The dashed box area indicates the simplified system. B. Biological schematic of TNF-α-induced NFκB pathway. Not all arrows represent direct physical interactions. Drugs used in this study and their key targets are highlighted. C. HUVECs were pretreated with three combinations at the same concentration 100 nM for 2 hours before being stimulated with 10 ng/ml TNF-α for 6 hours. Cells were lysed and output signaling protein was probed by western blotting. The level of β-actin was used as an internal control for normalization. The gray values are recorded at the bottom. D. Ratio of ICAM-1 to β-actin was determined with densitometry. C, control, T, 10 ng/ml TNF-α, G, Geldanamycin, A, Aldehyde, P, PS-1145.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 73

Metadata

Authors
Yan, H., Zhang, B., Li, S., & Zhao, Q.
Affiliations
Tsinghua University (CN)
Corresponding author
  • Li, Shao
  • Zhao, Qianchuan
Venue
BMC Systems Biology
Published
2010-04-25
Volume
4
Issue
1
Pages
50-50
ISSN
1752-0509 (ISSN-L)
OpenAlex
W2165982972
Cited by
73
References
46
Citations by year
2025: 1 · 2024: 16 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 5
FWCI
2.99
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Systems Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (60934004, 60721003, 60736027)
  • Project 211
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
drug synergy, NF-κB signaling, TNF-α, feedback loops, drug combination design
MeSH terms
Algorithms, Cells, Cultured, Chemistry, Pharmaceutical, Drug Combinations, Drug Evaluation, Preclinical, Drug Therapy, Endothelium, Vascular, Humans, Models, Biological, Models, Theoretical, Tumor Necrosis Factor-alpha, Models, Statistical, NF-kappa B, Treatment Outcome, Systems Biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway. https://app.cochat.ai/papers/10.1186/1752-0509-4-50
The paper
Yan, H., Zhang, B., Li, S., & Zhao, Q. (2010). A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway. BMC Systems Biology. https://doi.org/10.1186/1752-0509-4-50

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.